Longitudinal CSF measurements of alpha-synuclein, amyloid beta and tau in Parkinson disease
Objective: To evaluate whether cerebrospinal fluid (CSF) levels of alpha synuclein (Asyn), amyloid beta (Aβ) and tau change with disease progression and to evaluate whether…Analysis of levodopa use in patients with Parkinson’s Disease during pregnancy: a systematic review of the last twenty years
Objective: To evaluate the role of oral levodopa in patients with Parkinson’s disease (PD) during pregnancy, using the available literature, in order to determine the…Asymmetry and side concordance of rest tremor and bradykinesia in patients with essential tremor
Objective: In the present study, we aimed to investigate the clinical and kinematic features of rest tremor and bradykinesia in patients with essential tremor (ET),…Staged and simultaneous bilateral MRI-guided focused ultrasound treatment of essential tremor
Objective: The study aims to show that effective and safe bilateral MRgFUS treatment of ET is achievable. Background: Unilateral MRI-guided focused ultrasound (MRgFUS) thalamotomy reduces…Dystonia as presenting feature of Witteveen-kolk Syndrome
Objective: To describe the clinical heterogeneity and expand the phenotypic spectrum of Witteveen- Kolk syndrome Background: Witteveen-Kolk syndrome (WITKOS) is a neurodevelopmental condition, first described…A new synchronization method between inertial signals and local field potentials
Objective: This study aims to define a method to synchronize inertial signals recorded using wearable sensors and local field potentials recorded by the neurostimulator implanted…Reductions in OFF time with ND0612 for patients with Parkinson’s disease experiencing motor fluctuations: Responder-analysis from an open-label Phase 2 study
Objective: Evaluate the efficacy of subcutaneous levodopa/carbidopa infusion with investigational ND0612 in reducing OFF time in people with Parkinson’s disease (PwP) experiencing motor fluctuations. Background:…parkinson’s disease and coffee: is high consumption a protective factor or aversion to coffee taste a risk factor?
Objective: To evaluate the association between coffee consumption and preference for the taste of coffee with Parkinson's Disease (PD). Background: Previous studies point to a…Needs and priorities of people with Parkinson’s and care partners regarding neuropsychiatric symptoms
Objective: To examine the experiences of people with Parkinson’s disease (PD) and care partners (CPs) regarding cognitive, mood, behavioral, and sleep issues. Background: Neuropsychiatric symptoms…A 20-Year Follow-Up Case Report with Three DaT-SPECT Scans in Parkinson’s Disease Diagnosis
Objective: To describe a patient who underwent multiple DAT-SPECT scans over a 20-year clinical follow-up period in three distinct clinical settings: a normal scan excluding…
- « Previous Page
- 1
- …
- 78
- 79
- 80
- 81
- 82
- …
- 186
- Next Page »